A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

NCT07421232 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia and Mixed Hyperlipidemia

Interventions

DRUG: SYH2053/placebo injection
DRUG: Inclisiran (Leqvio®) 300mg

Sponsor

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.